2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 8.042 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income - EUR | 10.866 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Expenses - EUR | 13.966 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit/Loss - EUR | -3.100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Profit/Loss - EUR | -3.422 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Employees | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Violetpharm Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 502 | 506 | 501 | 492 | 483 | 474 | 465 | 455 | 456 | 455 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 273 | 276 | 273 | 268 | 263 | 258 | 253 | 248 | 248 | 248 |
Cash | 228 | 230 | 228 | 224 | 220 | 216 | 212 | 207 | 208 | 207 |
Shareholders Funds | -4.330 | -4.366 | -4.321 | -4.248 | -4.170 | -4.089 | -4.012 | -3.923 | -3.935 | -3.923 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 4.831 | 4.872 | 4.822 | 4.740 | 4.653 | 4.563 | 4.477 | 4.378 | 4.391 | 4.378 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Violetpharm Srl